约翰斯·霍普金斯大学：不论年龄、种族和起始体重，GLP-1减重药减重疗效基本一致！

Core Insights - The study published by Johns Hopkins University indicates that GLP-1 receptor agonists show similar weight loss effects across various demographics, but female patients experience significantly greater average weight loss compared to male patients [2][4]. Group 1: Study Overview - The research involved a systematic review and meta-analysis of 64 clinical trials, including drugs like semaglutide and dulaglutide, with tens of thousands of participants [4]. - Female patients lost an average of approximately 10.88% of their initial body weight, while male patients lost about 6.78%, with this difference being statistically significant [4]. - The study found no significant differences in weight loss effects among different age groups, races, ethnicities, initial body weights, or initial HbA1c levels, suggesting strong consistency in the efficacy of GLP-1 drugs across clinical populations [4]. Group 2: Mechanism and Implications - The authors suggest that the superior efficacy in women may be attributed to several factors, including the synergistic effect of estrogen, differences in drug metabolism, and typically lower median body weight in women [6]. - GLP-1 is a hormone secreted by intestinal cells after eating, which suppresses appetite and stimulates insulin release, promoting glucose uptake from the blood into tissues [6]. - Long-acting GLP-1 receptor agonists have been developed over the past two decades to mimic the effects of natural GLP-1, and these drugs are widely used for obesity and type 2 diabetes treatment, as well as reducing the risk of heart attacks and strokes [6]. Group 3: Future Research Directions - The analysis did not include tirzepatide due to its different pharmacological mechanism, as it also acts on GIP [6]. - The research team emphasizes the need for more studies to better understand the benefits of GLP-1 drugs in real-world clinical settings, especially for underrepresented populations in clinical trials [8]. - The study conveys two key messages: first, GLP-1 weight loss drugs are effective across most demographics, and second, female patients exhibit a more pronounced average weight loss compared to male patients [8].